HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Scott C Kogan Selected Research

Histone Deacetylases (Histone Deacetylase)

12/2007PPARgamma-active triterpenoid CDDO enhances ATRA-induced differentiation in APL.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Scott C Kogan Research Topics

Disease

23Leukemia
01/2021 - 04/2002
22Neoplasms (Cancer)
12/2023 - 10/2005
14Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 02/2003
11Acute Promyelocytic Leukemia
10/2018 - 04/2003
6Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2023 - 07/2015
4Lymphoma (Lymphomas)
01/2022 - 08/2006
4Carcinogenesis
01/2014 - 08/2006
4Genetic Translocation (Chromosomal Translocation)
03/2013 - 02/2003
4Myeloproliferative Disorders (Myeloproliferative Disorder)
09/2009 - 01/2004
3Hypersensitivity (Allergy)
12/2023 - 01/2004
3Myeloid Leukemia (Leukemia, Myelocytic)
03/2013 - 04/2003
2Inflammation (Inflammations)
01/2023 - 01/2022
2Thromboembolism
05/2021 - 02/2019
2Disease Progression
05/2006 - 06/2004
1Glucosephosphate Dehydrogenase Deficiency
12/2022
1Hemolysis
12/2022
1Anemia
12/2022
1Methemoglobinemia
12/2022
1Bites and Stings (Sting)
12/2022
1Urticaria (Hives)
12/2022
1Lymphoid Leukemia
01/2022
1B-Cell Leukemia (Leukemia, B Cell)
01/2022
1Dysbiosis
01/2022
1Hemorrhage
10/2021
1Body Weight (Weight, Body)
01/2021
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2020
1Hematologic Neoplasms (Hematological Malignancy)
01/2020
1Glucocorticoid Receptor Deficiency
01/2020
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
02/2019
1Acquired Immunodeficiency Syndrome (AIDS)
01/2018
1Myocardial Infarction
01/2018
1Neoplasm Metastasis (Metastasis)
01/2014
1Splenomegaly
10/2013

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
01/2020 - 02/2003
6Tretinoin (Retinoic Acid)FDA LinkGeneric
10/2016 - 04/2003
5CytokinesIBA
12/2023 - 07/2003
5Oncogene Proteins (Oncogene Protein)IBA
01/2018 - 01/2006
5Retinoic Acid Receptor alphaIBA
03/2013 - 02/2003
5promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA
12/2007 - 02/2003
4Transcription Factors (Transcription Factor)IBA
03/2013 - 07/2003
3Biomarkers (Surrogate Marker)IBA
12/2023 - 03/2010
3Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
10/2018 - 02/2011
3Small Interfering RNA (siRNA)IBA
12/2014 - 04/2011
3DNA (Deoxyribonucleic Acid)IBA
02/2011 - 02/2005
2Factor Xa InhibitorsIBA
10/2021 - 05/2021
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2021 - 06/2004
2Phosphotransferases (Kinase)IBA
01/2020 - 05/2006
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
05/2015 - 04/2003
2Tyrosine Kinase InhibitorsIBA
04/2014 - 04/2003
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2013 - 04/2006
2MethyltransferasesIBA
02/2011 - 09/2008
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2008 - 10/2005
2Neurofibromin 1 (Neurofibromin)IBA
09/2008 - 02/2007
2Sirolimus (Rapamycin)FDA Link
08/2008 - 08/2006
2GTPase-Activating Proteins (GTPase-Activating Protein)IBA
02/2007 - 06/2004
2CCAAT-Enhancer-Binding ProteinsIBA
04/2006 - 02/2003
1AntioxidantsIBA
01/2023
1Oxidants (Oxidizing Agents)IBA
12/2022
1Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
12/2022
1DapsoneFDA Link
12/2022
1Anti-Bacterial Agents (Antibiotics)IBA
01/2022
1Interleukin-10 (Interleukin 10)IBA
01/2022
1SmokeIBA
01/2021
1Interleukin-4 (Interleukin 4)IBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1Interleukin-8 (Interleukin 8)IBA
01/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021
1Mutant Proteins (Protein, Mutant)IBA
11/2020
1A-factor (Streptomyces)IBA
10/2020
12- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA
01/2020
1Cysteine (L-Cysteine)FDA Link
01/2020
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2020
1GlucocorticoidsIBA
01/2020
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
01/2020
1ArginaseIBA
11/2019
1Antiphospholipid AntibodiesIBA
02/2019
1Dietary IronIBA
01/2018
1Tyrosine (L-Tyrosine)FDA Link
04/2014
1quizartinibIBA
04/2014
1crenolanibIBA
04/2014
1Ligases (Synthetase)IBA
01/2014
1UbiquitinIBA
01/2014
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
10/2013
1Histone DemethylasesIBA
03/2013
1ChromatinIBA
08/2011
1Cyclin-Dependent Kinase Inhibitor p16IBA
04/2011
1Renilla LuciferasesIBA
04/2011
1Folic Acid (Vitamin M)FDA LinkGeneric
02/2011
1Azacitidine (5 Azacytidine)FDA Link
02/2011
1Choline (Choline Chloride)IBA
02/2011
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
09/2009
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
09/2009
1Arsenic Trioxide (Trisenox)FDA Link
01/2009
1O-(6)-methylguanineIBA
09/2008

Therapy/Procedure

15Therapeutics
11/2023 - 01/2005
4Drug Therapy (Chemotherapy)
12/2022 - 05/2006
1Transplantation
01/2021
1Hematopoietic Stem Cell Transplantation
01/2021
1Cranial Irradiation
01/2011
1Induction Chemotherapy
04/2009